Inhibition of norovirus replication by morpholino oligomers targeting the 5′-end of the genome

Virology

Volumn 380, Issue 2, 2008, Pages 328-337

  Bok, Karin ^a   Cavanaugh, Victoria J ^b   Matson, David O ^b   González Molleda, Lorenzo ^c   Chang, Kyeong Ok ^d   Zintz, Carmelann ^b   Smith, Alvin W ^e   Iversen, Patrick ^f   Green, Kim Y ^a   Campbell, Ann E ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF OVIEDO   (Spain)

^d KANSAS STATE UNIVERSITY   (United States)

^e OREGON STATE UNIVERSITY   (United States)

^f AVI BIOPHARMA INC   (United States)

Author keywords

Antisense; Antiviral; Norovirus; PMO

Indexed keywords

LUCIFERASE; OLIGOMER; PEPTIDE; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER A; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER B; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER C; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER D; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER E; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER F; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER G; PHOSPHORODIAMIDIATE MORPHOLINO OLIGOMER H; POLYMER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ASSAY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NOROVIRUS; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; HUMANS; MICE; MORPHOLINES; NOROVIRUS; PROTEIN BIOSYNTHESIS; RNA, VIRAL; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); MURINE NOROVIRUS; NOROVIRUS; NORWALK VIRUS;

EID: 53449099174     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.007     Document Type: Article

References (39)

1. Abes S., Moulton H.M., Clair P., Prevot P., Youngblood D.S., Wu R.P., Iversen P.L., and Lebleu B. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control. Release. 116 3 (2006) 304-313
2. Bertolotti-Ciarlet A., Crawford S.E., Hutson A.M., and Estes M.K. The 3¢ end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol. 77 21 (2003) 11603-11615
3. Bull R.A., Tu E.T., McIver C.J., Rawlinson W.D., and White P.A. Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J. Clin. Microbiol. 44 2 (2006) 327-333
4. Burrer R., Neuman B.W., Ting J.P., Stein D.A., Moulton H.M., Iversen P.L., Kuhn P., and Buchmeier M.J. Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models. J. Virol. 81 11 (2007) 5637-5648
5. Chang K.O., and George D.W. Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells. J. Virol. 81 22 (2007) 12111-12118
6. Chang K.O., Sosnovtsev S.V., Belliot G., King A.D., and Green K.Y. Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology 353 2 (2006) 463-473
7. Chaudhry Y., Skinner M.A., and Goodfellow I.G. Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J. Gen. Virol. 88 Pt 8 (2007) 2091-2100
8. Deas T.S., Bennett C.J., Jones S.A., Tilgner M., Ren P., Behr M.J., Stein D.A., Iversen P.L., Kramer L.D., Bernard K.A., and Shi P.Y. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus. Antimicrob. Agents. Chemother. 51 7 (2007) 2470-2482
9. Estes M.K., Ball J.M., Guerrero R.A., Opekun A.R., Gilger M.A., Pacheco S.S., and Graham D.Y. Norwalk virus vaccines: challenges and progress. J. Infect. Dis. 181 Suppl 2 (2000) S367-373
10. Ge Q., Pastey M., Kobasa D., Puthavathana P., Lupfer C., Bestwick R.K., Iversen P.L., Chen J., and Stein D.A. Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers. Antimicrob. Agents. Chemother. 50 11 (2006) 3724-3733
11. Ghosh C., Stein D., Weller D., and Iversen P. Evaluation of antisense mechanisms of action. Methods. Enzymol. 313 (2000) 135-143
12. Glass R.I., Noel J., Ando T., Fankhauser R., Belliot G., Mounts A., Parashar U.D., Bresee J.S., and Monroe S.S. The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J. Infect. Dis. 181 Suppl 2 (2000) S254-261
13. Green K.Y. Caliciviridae: the Noroviruses. In: Knipe D.M. (Ed). Fields Virology. Fifth ed. Vol. I (2007), Lippincott Williams and Wilkins, a Wolters Kluwer Business, Philadelphia 949-979 2 vols
14. Heintges T., Encke J., zu Putlitz J., and Wands J.R. Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor. J. Med. Virol. 65 4 (2001) 671-680
15. Iversen P.L. Phosphorodiamidate morpholino oligomers. Antisense Drug Technology (2001), Marcel Dekker, New York 375-389
16. Kirkwood C. Viral gastroenteritis in Europe: a new norovirus variant?. Lancet 363 9410 (2004) 671-672
17. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., and Baric R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9 5 (2003) 548-553
18. Liu, P., Moe, C., 2006. Real-time RT-PCR detection of Norwalk virus.
19. Moulton H.M., Nelson M.H., Hatlevig S.A., Reddy M.T., and Iversen P.L. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjug. Chem. 15 2 (2004) 290-299
20. Mumphrey S.M., Changotra H., Moore T.N., Heimann-Nichols E.R., Wobus C.E., Reilly M.J., Moghadamfalahi M., Shukla D., and Karst S.M. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81 7 (2007) 3251-3263
21. Neuman B.W., Stein D.A., Kroeker A.D., Churchill M.J., Kim A.M., Kuhn P., Dawson P., Moulton H.M., Bestwick R.K., Iversen P.L., and Buchmeier M.J. Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. J. Virol. 79 15 (2005) 9665-9676
22. Parrino T.A., Schreiber D.S., Trier J.S., Kapikian A.Z., and Blacklow N.R. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297 2 (1977) 86-89
23. Patel D., Opriessnig T., Stein D.A., Halbur P.G., Meng X.J., Iversen P.L., and Zhang Y.J. Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication. Antiviral. Res. 77 2 (2008) 95-107
24. Simmonds P., Karakasiliotis I., Bailey D., Chaudhry Y., Evans D.J., and Goodfellow I.G. Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic. Acids. Res. (2008)
25. Smith A.W., Matson D.O., Stein D.A., Skilling D.E., Kroeker A.D., Berke T., and Iversen P.L. Antisense treatment of Caliciviridae: an emerging disease agent of animals and humans. Curr. Opin. Mol. Ther. 4 2 (2002) 177-184
26. Smith A.W., Iversen P.L., O'Hanley P.D., Skilling D.E., Christensen J.R., Weaver S.S., Longley K., Stone M.A., Poet S.E., and Matson D.O. Virus-specific antiviral treatment for controlling severe and fatal outbreaks of feline calicivirus infection. Am. J. Vet. Res. 69 1 (2008) 23-32
27. Sosnovtsev S.V., Belliot G., Chang K.O., Prikhodko V.G., Thackray L.B., Wobus C.E., Karst S.M., Virgin H.W., and Green K.Y. Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J. Virol. 80 16 (2006) 7816-7831
28. Stein D., Foster E., Huang S.B., Weller D., and Summerton J. A specificity comparison of four antisense types: morpholino, 2¢-O-methyl RNA, DNA, and phosphorothioate DNA. Antisense. Nucleic. Acid. Drug. Dev. 7 3 (1997) 151-157
29. Stein D.A., Skilling D.E., Iversen P.L., and Smith A.W. Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers. Antisense. Nucleic. Acid. Drug. Dev. 11 5 (2001) 317-325
30. Summerton J. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta. 1489 1 (1999) 141-158
31. Thackray L.B., Wobus C.E., Chachu K.A., Liu B., Alegre E.R., Henderson K.S., Kelley S.T., and Virgin H.W.T. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 81 19 (2007) 10460-10473
32. Vagnozzi A., Stein D.A., Iversen P.L., and Rieder E. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. J. Virol. 81 21 (2007) 11669-11680
33. Wang A., Cheung P.K., Zhang H., Carthy C.M., Bohunek L., Wilson J.E., McManus B.M., and Yang D. Specific inhibition of coxsackievirus B3 translation and replication by phosphorothioate antisense oligodeoxynucleotides. Antimicrob. Agents. Chemother. 45 4 (2001) 1043-1052
34. Ward V.K., McCormick C.J., Clarke I.N., Salim O., Wobus C.E., Thackray L.B., Virgin H.W.T., and Lambden P.R. Recovery of infectious murine norovirus using pol II-driven expression of full-length cDNA. Proc. Natl. Acad. Sci. U. S. A. 104 26 (2007) 11050-11055
35. Wobus C.E., Karst S.M., Thackray L.B., Chang K.O., Sosnovtsev S.V., Belliot G., Krug A., Mackenzie J.M., Green K.Y., and Virgin H.W. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS. Biol. 2 12 (2004) e432
36. Wobus C.E., Thackray L.B., and Virgin H.W.T. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 80 11 (2006) 5104-5112
37. Yang L., Yao J., and Deng L. Inhibitory effect of phosphorothioae oligodeoxynucleotides on HBV replication and synthesis of antigen in vitro. Zhonghua. Yi. Xue. Za. Zhi. 79 11 (1999) 857-859
38. Zheng D.P., Ando T., Fankhauser R.L., Beard R.S., Glass R.I., and Monroe S.S. Norovirus classification and proposed strain nomenclature. Virology 346 2 (2006) 312-323
39. Zintz C., Bok K., Parada E., Barnes-Eley M., Berke T., Staat M.A., Azimi P., Jiang X., and Matson D.O. Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect. Genet. Evol. 5 3 (2005) 281-290